Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 91 citing articles:

Exploring the next generation of antibody–drug conjugates
Kyoji Tsuchikama, Yasuaki Anami, Summer Y. Y. Ha, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 3, pp. 203-223
Open Access | Times Cited: 188
Potential of antibody–drug conjugates (ADCs) for cancer therapy
Hany E. Marei, Carlo Cenciarelli, Anwarul Hasan
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 81
A comprehensive review of key factors affecting the efficacy of antibody drug conjugate
Anupama Samantasinghar, Naina Sunildutt, Faheem Ahmed, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114408-114408
Open Access | Times Cited: 69
Colorimetric sensing for translational applications: from colorants to mechanisms
Zhicheng Jin, Wonjun Yim, Maurice Retout, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 15, pp. 7681-7741
Closed Access | Times Cited: 37
Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01
Aditya Bardia, Komal Jhaveri, Seock‐Ah Im, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 20
The Use of Antibody-Antibiotic Conjugates to Fight Bacterial Infections
Marco Cavaco, Miguel A. R. B. Castanho, Vera Neves
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 51
A beginner’s guide to current synthetic linker strategies towards VHL-recruiting PROTACs
Nikol A. Zografou-Barredo, Alex J. Hallatt, J. S. JUN. RICCI, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 88-89, pp. 117334-117334
Open Access | Times Cited: 34
TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in pre-treated inoperable or metastatic HR+/HER2– breast cancer
Aditya Bardia, Komal Jhaveri, Kevin Kalinsky, et al.
Future Oncology (2023) Vol. 20, Iss. 8, pp. 423-436
Open Access | Times Cited: 34
Antibody-Drug Conjugate Overview: a State-of-the-art Manufacturing Process and Control Strategy
Meng Li, Xueyu Zhao, Chuanfei Yu, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 3, pp. 419-440
Closed Access | Times Cited: 13
Homogeneous multi-payload antibody–drug conjugates
Toby Journeaux, Gonçalo J. L. Bernardes
Nature Chemistry (2024) Vol. 16, Iss. 6, pp. 854-870
Closed Access | Times Cited: 13
Therapeutic synthetic and natural materials for immunoengineering
Anna Slezak, Kevin Chang, Samir Hossainy, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 4, pp. 1789-1822
Open Access | Times Cited: 11
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice
Ling Zhou, Yunlong Lu, Wei Liu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
Li-Chung Tsao, John S. Wang, Xingru Ma, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Multivalent protein-drug conjugates – An emerging strategy for the upgraded precision and efficiency of drug delivery to cancer cells
Natalia Porębska, Krzysztof Ciura, Aleksandra Chorążewska, et al.
Biotechnology Advances (2023) Vol. 67, pp. 108213-108213
Open Access | Times Cited: 19
Small molecule– and peptide–drug conjugates addressing integrins: A story of targeted cancer treatment
Jannik Paulus, Norbert Sewald
Journal of Peptide Science (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 6
Antibody drug conjugates in the clinic
Edidiong Udofa, Disha Sankholkar, Samir Mitragotri, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 6
Open Access | Times Cited: 6
Antibody–drug conjugates in cancer therapy: mechanisms and clinical studies
Jun He, Xianghua Zeng, Chunmei Wang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 6
Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability In Vivo
Yue Huang, Hui Yin Tan, Jiaqi Yuan, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 42, pp. 16525-16533
Open Access | Times Cited: 6
Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying its Stability In Vivo
Yue Huang, Hui Yin Tan, Jiaqi Yuan, et al.
(2024)
Open Access | Times Cited: 5
Antibody drug conjugates in non-small cell lung cancer: An emerging therapeutic approach
Stanley M. Marks, Jarushka Naidoo
Lung Cancer (2021) Vol. 163, pp. 59-68
Open Access | Times Cited: 29
Therapeutic antibodies for precise cancer immunotherapy: current and future perspectives
Longchao Liu, Jiahui Chen
Medical Review (2022) Vol. 2, Iss. 6, pp. 555-569
Open Access | Times Cited: 19
Synthesis and biological evaluation of theranostic Trastuzumab–SN38 conjugate for Near-IR fluorescence imaging and targeted therapy of HER2+ breast cancer
Dmytro Kobzev, Chandrashekhar Prasad, Dipak Walunj, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115298-115298
Closed Access | Times Cited: 11
Current developments and prospects of the antibiotic delivery systems
Kusum Kharga, Shubhang Jha, Tanvi Vishwakarma, et al.
Critical Reviews in Microbiology (2024), pp. 1-40
Closed Access | Times Cited: 4
Antibody–Drug Conjugates in the Treatment of Genitourinary Cancers: An Updated Review of Data
Prathana Nathan, Adnan Rajeh, Meh Noor, et al.
Current Oncology (2024) Vol. 31, Iss. 4, pp. 2316-2327
Open Access | Times Cited: 4
Structure–Activity Relationship of Antibody–Oligonucleotide Conjugates: Evaluating Bioconjugation Strategies for Antibody–siRNA Conjugates for Drug Development
Michael A. Cochran, Danny Arias, Rob S. Burke, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 14852-14867
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top